Kit For The Preparation Of Technetium Tc 99m Pentetate Injection, Powder, Lyophilized, For Solution
NDC Package 69945-314-30
Package Information
Kit For The Preparation Of Technetium Tc 99m Pentetate injection is after radiolabeling with Technetium Tc 99m, is indicated for. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Curium Us Llc, this product is identified by NDC 69945-314 and is authorized under FDA application ANDA215146.
Identification & Billing
Clinical Specifications
- Intravenous - Administration within or into a vein or veins.
- Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Regulatory & Marketing
Hierarchy Structure
- 69945 - Curium Us Llc
- 69945-314 - Kit For The Preparation Of Technetium Tc 99m Pentetate
- 69945-314-30 - 30 VIAL in 1 CARTON / 10 mL in 1 VIAL (69945-314-01)
- 69945-314 - Kit For The Preparation Of Technetium Tc 99m Pentetate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69945-314). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69945-314-30 identifies a specific commercial package of 30 vial in 1 carton / 10 ml in 1 vial (69945-314-01) of Kit For The Preparation Of Technetium Tc 99m Pentetate, a human prescription drug labeled by Curium Us Llc. This injection, powder, lyophilized, for solution is formulated for intravenous; respiratory (inhalation) use and contains pentetic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Curium Us Llc on April 08, 2025. The current certification is valid through December 31, 2026.
How is this Curium Us Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69945031430. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.